A retrospective study exploring the safety and efficacy of hepatic arterial infusion chemotherapy and sequential transarterial embolization combined with lenvatinib and tislelizumab in unresectable hepatocellular carcinoma

被引：0
|
作者：
Zhong, Jian-Hong [1 ]
Chen, Zu-Shun [1 ]
Qi, Lu-Nan [1 ]
Zhang, Zhi-Ming [1 ]
Xiang, Bang-De [1 ]
Ma, Liang [1 ]
机构：
[1] Guangxi Med Univ Canc Hosp, Nanning, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16219
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study
    Shen, Chenyu
    Jiang, Wenxi
    Chen, Ruiqing
    Li, Lingbing
    Wu, Yunbo
    Tan, Long
    Chen, Yadong
    Zhang, Weiqiang
    Wang, Zhijun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (09)
  • [22] Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma
    Xu, Yu-Jie
    Lai, Zhi-Cheng
    He, Min-Ke
    Bu, Xiao-Yun
    Chen, Huan-Wei
    Zhou, Yuan-Min
    Xu, Li
    Wei, Wei
    Zhang, Yao-Jun
    Chen, Min-Shan
    Guo, Rong-Ping
    Shi, Ming
    Li, Qi-Jiong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [23] A real-world experience of hepatic arterial infusion chemotherapy combined with tislelizumab and lenvatinib for unresectable hepatocellular carcinoma with type IV portal vein tumor thrombus.
    Li, Xiaowei
    Cao, Kunkun
    Fu, Zhigang
    Zhong, Jiaming
    Liu, Li
    Chen, Xiaoxia
    Ding, Ning
    Zhang, Xiaoli
    Qu, Zengqiang
    Zhai, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Efficacy and safety of lenvatinib plus adebrelimab combined with hepatic arterial infusion chemotherapy (HAIC) for unresectable biliary tract cancer
    Cai, H.
    Tang, S.
    Guo, W.
    ANNALS OF ONCOLOGY, 2024, 35 : S1478 - S1479
  • [25] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study
    Zhang, Jin-Xing
    Chen, Yu-Xing
    Zhou, Chun-Gao
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    HEPATOLOGY RESEARCH, 2022, 52 (09) : 794 - 803
  • [26] Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
    Tsai, Wei-Lun
    Sun, Wei-Chi
    Chen, Wen-Chi
    Chiang, Chia-Ling
    Lin, Huey-Shyan
    Liang, Huei-Lung
    Cheng, Jin-Shiung
    MEDICINE, 2020, 99 (32) : E21489
  • [27] Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion
    Zhang, Yufeng
    Zhang, Haiyan
    Xu, Haoqian
    Wang, Ying
    Feng, Long
    Yi, Fengming
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [28] FOLFOX-based hepatic arterial infusion chemotherapy combined with sequential drug-eluting bead transarterial chemoembolization for unresectable large hepatocellular carcinoma
    Zhao, R.
    Zhou, J.
    Li, S.
    Wei, W.
    Guo, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S1485 - S1485
  • [29] Efficacy and safety of HepaSphere drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
    Liu, Baojiang
    Gao, Song
    Guo, Jianhai
    Kou, Fuxin
    Liu, Shaoxing
    Zhang, Xin
    Feng, Aiwei
    Wang, Xiaodong
    Cao, Guang
    Chen, Hui
    Liu, Peng
    Xu, Haifeng
    Gao, Qinzong
    Yang, Renjie
    Zhu, Xu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Atezolizumab plus bevacizumab combined with transarterial chemoembolization and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma with high tumor burden
    Qiu, J.
    Huang, Z.
    He, W.
    Li, B-K.
    Yuan, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S615 - S615
12345